Dietary Intervention for Post-Liver Transplant Health
Trial Summary
What is the purpose of this trial?
The purpose of this study is to study the effects of a structured Mediterranean dietary program on prevention of weight gain, promotion of heart health and prevention of fatty liver disease after liver transplantation.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Mediterranean Diet treatment for post-liver transplant health?
Following a Mediterranean dietary pattern has been shown to reduce cardiometabolic risk, which is important for liver transplant recipients who face higher risks of heart-related issues. Additionally, a study found that a combined intervention of exercise and dietary counseling, which included dietary modifications, improved exercise capacity and general health in liver transplant patients.12345
Is the Mediterranean diet safe for liver transplant patients?
The Mediterranean diet is generally considered safe for humans and has been shown to have health benefits, such as reducing cardiovascular risk factors and having anti-inflammatory properties. It is often recommended for its positive effects on overall health, including for those who have undergone organ transplants.13678
How does the Mediterranean Diet treatment differ from other treatments for post-liver transplant health?
The Mediterranean Diet is unique for post-liver transplant health because it focuses on a balanced intake of fruits, vegetables, whole grains, and healthy fats, which can help reduce cardiometabolic risks that are common after a liver transplant. Unlike specific drugs, this diet offers a holistic approach to improving overall health and managing risk factors through dietary changes.123910
Research Team
Kymberly Watt, MD
Principal Investigator
Mayo Clinic
Eligibility Criteria
This trial is for adults over 18 who've had a liver transplant, have a BMI ≥ 25 adjusted for fluid in the belly (ascites), and good graft function. It's not for those with certain types of liver cancer, multiple organ transplants, heavy protein loss in urine, uncontrolled diabetes, pregnancy or plans to become pregnant soon, history of weight-loss surgery, untreated post-transplant complications or conditions that make it unsafe to follow a special diet.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either the Dietary Intervention arm or the Standard of Care arm and followed for dietary and lifestyle interventions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Mediterranean Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor